Michel, L. L., Sommer, L., González Silos, R., Lorenzo Bermejo, J., Au, A. v., Seitz, J., . . . Marmé, F. (2019). Locoregional risk assessment after neoadjuvant chemotherapy in patients with primary breast cancer: Clinical utility of the CPS + EG score. Breast cancer research and treatment, 177(2), . https://doi.org/10.1007/s10549-019-05314-9
Chicago-Zitierstil (17. Ausg.)Michel, Laura L., et al. "Locoregional Risk Assessment After Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer: Clinical Utility of the CPS + EG Score." Breast Cancer Research and Treatment 177, no. 2 (2019). https://doi.org/10.1007/s10549-019-05314-9.
MLA-Zitierstil (9. Ausg.)Michel, Laura L., et al. "Locoregional Risk Assessment After Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer: Clinical Utility of the CPS + EG Score." Breast Cancer Research and Treatment, vol. 177, no. 2, 2019, https://doi.org/10.1007/s10549-019-05314-9.